Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

Assembly 13: placing the pulmonary circulation in the heart of ERS

Anton Vonk Noordegraaf, Marion Delcroix, David Jiminez, Oliver Sitbon, Harm Jan Bogaard
Breathe 2019 15: 88-89; DOI: 10.1183/20734735.0349-2018
Anton Vonk Noordegraaf
1Amsterdam UMC, Vrije Universiteit Amsterdam, Dept of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: a.vonk@vumc.nl
Marion Delcroix
2Dept of Pulmonary Medicine, UZ Leuven, Leuven, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marion Delcroix
David Jiminez
3Respiratory Dept and Medicine Dept, Ramon y Cajal Hospital IRYCIS, and Alcala de Henares University, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Jiminez
Oliver Sitbon
4Service de Pneumologie et Soins Intensifs, AP-HP, Hôpital de Bicêtre - Université Paris-Sud, Le Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Oliver Sitbon
Harm Jan Bogaard
1Amsterdam UMC, Vrije Universiteit Amsterdam, Dept of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Meet @ERStalk Assembly 13: pulmonary vascular diseases http://ow.ly/9t2430n2MhU

In 1988, Henri Denolin stated that the “pulmonary circulation is a kind of no-man's land between pulmonology and cardiology for everyone except physiologists”. In the years thereafter, the pulmonary field took over from the physiologist, expanding both our knowledge on the pulmonary circulation and the pathobiology of the different diseases affecting the pulmonary circulation. Novel clinical diagnostic tools made it possible to identify abnormal pulmonary circulatory conditions in a noninvasive way. Results from many studies showed that the pulmonary circulation is affected in almost all the currently known respiratory diseases and that the presence of pulmonary hypertension in any respiratory disease is associated with a poor outcome. The cause of death is inevitably the failing right ventricle. In addition, we came to recognise that pulmonary embolism and pulmonary arterial hypertension are far more frequent than had been assumed in the old days. The formation of centres of expertise in Europe was the next step leading to success. Scientific breakthroughs in these centres of expertise paved the way for the development of successful novel treatment. 30 years after the statement of Henri Denolin the European Respiratory Society (ERS) decided to create Assembly 13, entirely devoted to the pulmonary circulation, acknowledging the importance of the pulmonary circulation in respiratory diseases and the progress made in the field.

The goal of our Assembly is to create the best educational and research platform in the world in the field of pulmonary hypertension. To serve this purpose a pulmonary hypertension group, a pulmonary embolism group and a right ventricle group were created. Many initiatives are currently being undertaken to increase the educational and scientific impact of our assembly within the ERS. To increase our impact on the society we have developed the following initiatives.

  • Expanding our educational activities. A number of initiatives are currently expanding our educational programme in this area. In 2019 we will have our first ERS course on pulmonary embolism and it is planned to repeat this activity every 2 years.

  • Since our field is interdisciplinary, we will strengthen our collaboration with other societies including the European Society of Cardiology, American Thoracic Society, International Society of Heart and Lung Transplantation, Pulmonary Vascular Research Institute and American Heart Association. In addition, ERS wants to be a platform for pulmonary vascular radiologists and pathologists interested in the pulmonary circulation.

  • Translational research in the field of pulmonary vascular disease is very strongly represented in Europe. Our assembly will seek better ways to serve the scientists in this area with the support of leading scientists and by creating multidisciplinary task forces.

  • Finally, since the pulmonary circulation is involved in almost every pulmonary disease, we will work closely with the other Assemblies to create proposals for symposia, task forces and other education activities.

Although still small in terms of our number of members, we believe that this situation will change quickly in the coming years showing that the pulmonary circulation is a no man's land no more.

Footnotes

  • Conflict of interest: A. Vonk Noordegraaf received speakers’ money from Actelion, MSD, Pfizer, Bayer and GSK in the past 10 years. In addition, he served as a member of the scientific advisory board of Morphogen-XI.

  • Conflict of interest: M. Delcroix reports research grants and personal fees (investigator, speaker and consultant fees) from Actelion, personal fees (investigator, speaker and consultant fees) from Bayer, personal fees (investigator, speaker and consultant fees) from GSK, personal fees (speaker and consultant fees) from MSD, personal fees (investigator fees) from Reata, personal fees (investigator and consultant fees) from Bellarophon, personal fees (investigator fees) from Eli Lilly, outside the submitted work.

  • Conflict of interest: D. Jimenez reports personal fees from Bayer, BMS, Pfizer, Rovi and Sanofi, and grants and personal fees from Daiichi-Sankyo, outside the submitted work.

  • Conflict of interest: O. Sitbon reports grants, personal fees and non-financial support from Actelion Pharmaceuticals, GSK and MSD (research and educational grants, and investigator, speaker's fees and consultancy services), grants and personal fees from Bayer (research and educational grants, and investigator, speaker's fees and consultancy services), and personal fees from Arena Pharmaceuticals (consultancy services), outside the submitted work.

  • Conflict of interest: H.J. Bogaard has nothing to disclose.

  • Copyright ©ERS 2019

Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

PreviousNext
Back to top
Vol 15 Issue 1 Table of Contents
Breathe: 15 (1)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Assembly 13: placing the pulmonary circulation in the heart of ERS
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Assembly 13: placing the pulmonary circulation in the heart of ERS
Anton Vonk Noordegraaf, Marion Delcroix, David Jiminez, Oliver Sitbon, Harm Jan Bogaard
Breathe Mar 2019, 15 (1) 88-89; DOI: 10.1183/20734735.0349-2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Assembly 13: placing the pulmonary circulation in the heart of ERS
Anton Vonk Noordegraaf, Marion Delcroix, David Jiminez, Oliver Sitbon, Harm Jan Bogaard
Breathe Mar 2019, 15 (1) 88-89; DOI: 10.1183/20734735.0349-2018
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary vascular disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Expert opinion

  • Lung cancer screening by volume CT
  • In pursuit of the primary
  • A rare complication in a case of nonsmall cell lung carcinoma
Show more Expert opinion

Meet the Assemblies

  • Meet Assembly 14
  • Meet Assembly 7
  • Meet Assembly 1
Show more Meet the Assemblies

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society